AI Matches or Outperforms Human Specialists in Retina and Glaucoma Management

A large language model (LLM) artificial intelligence (AI) system can match, or in some cases outperform, human ophthalmologists in the diagnosis and treatment of patients with glaucoma and retina disease, according to research from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

The provocative study, published February 22, in JAMA Ophthalmology, suggests that advanced AI tools, which are trained on vast amounts of data, text, and images, could play an important role in providing decision-making support to ophthalmologists in the diagnosis and management of cases involving glaucoma and retina disorders, which afflict millions of patients.

The study matched the knowledge of ophthalmic specialists against the capabilities of the latest generation AI system, GPT-4 (Generative Pre-Training–Model 4) from OpenAI, designed to replicate human-level performance. Within medicine, sophisticated AI tools are seen as potentially revolutionizing diagnosis and treatment tools through the accuracy and comprehensiveness of their LLM-generated responses. Ophthalmology, with its high volume of often complex patients, could be a particularly fertile field for AI, giving specialists more time to practice evidence-based medicine.

"The performance of GPT-4 in our study was quite eye-opening," says Andy Huang, MD, an ophthalmology resident at NYEE, and lead author of the study. "We recognized the enormous potential of this AI system from the moment we started testing it and were fascinated to observe that GPT-4 could not only assist but in some cases match or exceed, the expertise of seasoned ophthalmic specialists."

For the human side of its study, the Mount Sinai team recruited 12 attending specialists and three senior trainees from the Department of Ophthalmology at the Icahn School of Medicine at Mount Sinai. A basic set of 20 questions (10 each for glaucoma and retina) from the American Academy of Ophthalmology’s list of commonly asked questions by patients was randomly selected, along with 20 deidentified patient cases culled from Mount Sinai-affiliated eye clinics. Responses from both the GPT-4/AI system and human specialists were then statistically analyzed and rated for accuracy and thoroughness using a Likert scale, which is commonly used in clinical research to score responses.

The results showed that AI matched or outperformed human specialists in both accuracy and completeness of its medical advice and assessments. More specifically, AI demonstrated superior performance in response to glaucoma questions and case-management advice, while reflecting a more balanced outcome in retina questions, where AI matched humans in accuracy but exceeded them in completeness.

"AI was particularly surprising in its proficiency in handling both glaucoma and retina patient cases, matching the accuracy and completeness of diagnoses and treatment suggestions made by human doctors in a clinical note format," says Louis R. Pasquale, MD, FARVO, Deputy Chair for Ophthalmology Research for the Department of Ophthalmology, and senior author of the study. "Just as the AI application Grammarly can teach us how to be better writers, GPT-4 can give us valuable guidance on how to be better clinicians, especially in terms of how we document findings of patient exams."

While emphasizing that additional testing is needed, Dr. Huang believes this work points to a promising future for AI in ophthalmology. "It could serve as a reliable assistant to eye specialists by providing diagnostic support and potentially easing their workload, especially in complex cases or areas of high patient volume," he explains. "For patients, the integration of AI into mainstream ophthalmic practice could result in quicker access to expert advice, coupled with more informed decision-making to guide their treatment."

Huang AS, Hirabayashi K, Barna L, Parikh D, Pasquale LR.
Assessment of a Large Language Model's Responses to Questions and Cases About Glaucoma and Retina Management.
JAMA Ophthalmol. 2024 Feb 22:e236917. doi: 10.1001/jamaophthalmol.2023.6917

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...